Terms: = Uterine cancer AND Ki-67 AND Staging
25 results:
1. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of CD34, podoplanin and ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
[TBL] [Abstract] [Full Text] [Related]
3. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract] [Full Text] [Related]
4. Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial cancer: A Randomized Double-blind Placebo-Controlled Trial.
Petchsila K; Prueksaritanond N; Insin P; Yanaranop M; Chotikawichean N
Asian Pac J Cancer Prev; 2020 Mar; 21(3):733-741. PubMed ID: 32212801
[TBL] [Abstract] [Full Text] [Related]
5. Expression of ER, PR, C-erbB-2 and ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract] [Full Text] [Related]
6. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.
Visser NC; Bulten J; van der Wurff AA; Boss EA; Bronkhorst CM; Feijen HW; Haartsen JE; van Herk HA; de Kievit IM; Klinkhamer PJ; Pijlman BM; Snijders MP; Vandenput I; Vos MC; de Wit PE; van de Poll-Franse LV; Massuger LF; Pijnenborg JM
BMC Cancer; 2015 Jun; 15():487. PubMed ID: 26123742
[TBL] [Abstract] [Full Text] [Related]
7. Expression of Vimentin and ki-67 Proteins in Cervical Squamous Cell Carcinoma and their Relationships with Clinicopathological Features.
Yu JQ; Zhou Q; Zheng YF; Bao Y
Asian Pac J Cancer Prev; 2015; 16(10):4271-5. PubMed ID: 26028085
[TBL] [Abstract] [Full Text] [Related]
8. Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors.
Stănescu AD; Nistor E; Sajin M; Stepan AE
Rom J Morphol Embryol; 2014; 55(3 Suppl):1129-36. PubMed ID: 25607395
[TBL] [Abstract] [Full Text] [Related]
9. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract] [Full Text] [Related]
10. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
[TBL] [Abstract] [Full Text] [Related]
12. [The value of ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract] [Full Text] [Related]
13. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix.
Katagiri A; Nakayama K; Rahman MT; Rahman M; Katagiri H; Ishikawa M; Ishibashi T; Iida K; Otsuki Y; Nakayama S; Miyazaki K
Int J Gynecol Cancer; 2012 Feb; 22(2):208-12. PubMed ID: 22274316
[TBL] [Abstract] [Full Text] [Related]
14. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract] [Full Text] [Related]
15. Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
Tsujikawa T; Yoshida Y; Kiyono Y; Kurokawa T; Kudo T; Fujibayashi Y; Kotsuji F; Okazawa H
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):37-45. PubMed ID: 20717823
[TBL] [Abstract] [Full Text] [Related]
16. Primary bilateral ovarian and uterine Burkitt's lymphoma following chemotherapy for breast cancer.
Hatami M; Whitney K; Goldberg GL
Arch Gynecol Obstet; 2010 Apr; 281(4):697-702. PubMed ID: 19756677
[TBL] [Abstract] [Full Text] [Related]
17. Expression of p53, bcl-2 and ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
[TBL] [Abstract] [Full Text] [Related]
18. [Association of p16, p53, ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract] [Full Text] [Related]
19. The expression of ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
[TBL] [Abstract] [Full Text] [Related]
20. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M; Akahira J; Moriya T; Suzuki T; Yaegashi N; Sasano H
Cancer Sci; 2003 Nov; 94(11):980-5. PubMed ID: 14611675
[TBL] [Abstract] [Full Text] [Related]
[Next]